(0.33%) 5 116.58 points
(0.33%) 38 364 points
(0.37%) 15 986 points
(-0.93%) $83.07
(5.56%) $2.03
(0.34%) $2 355.10
(0.46%) $27.66
(4.05%) $959.45
(-0.26%) $0.932
(-0.41%) $10.98
(-0.57%) $0.796
(1.69%) $93.43
Live Chart Being Loaded With Signals
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples...
Stats | |
---|---|
本日の出来高 | 33.91M |
平均出来高 | 2.27M |
時価総額 | 396.23M |
EPS | $0 ( 2024-03-26 ) |
次の収益日 | ( $0 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.04 |
ATR14 | $0.167 (7.95%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-05 | Taich Adam | Sell | 48 425 | Common Stock |
2024-01-05 | Taich Adam | Sell | 185 812 | Stock Option (Right to buy) |
2024-01-05 | Taich Adam | Sell | 110 000 | Stock Option (Right to buy) |
2024-01-05 | Taich Adam | Sell | 145 000 | Stock Option (Right to buy) |
2024-01-05 | Taich Adam | Sell | 150 000 | Stock Option (Right to buy) |
INSIDER POWER |
---|
-85.54 |
Last 95 transactions |
Buy: 2 347 082 | Sell: 20 640 281 |
ボリューム 相関
SomaLogic, Inc. 相関 - 通貨/商品
SomaLogic, Inc. 財務諸表
Annual | 2022 |
収益: | $97.67M |
総利益: | $54.30M (55.60 %) |
EPS: | $-0.590 |
FY | 2022 |
収益: | $97.67M |
総利益: | $54.30M (55.60 %) |
EPS: | $-0.590 |
FY | 2021 |
収益: | $81.63M |
総利益: | $16.06M (19.68 %) |
EPS: | $-0.00100 |
Financial Reports:
No articles found.
SomaLogic, Inc.
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal research use only and laboratory-developed tests. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions, as well as facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。